Ventyx Biosciences, Inc. Common Stock (VTYX) is a publicly traded Healthcare sector company. As of May 21, 2026, VTYX trades at $14.00 with a market cap of $1.00B and a P/E ratio of -7.11. VTYX moved +0.07% today. Year to date, VTYX is +253.53%; over the trailing twelve months it is +872.22%. Its 52-week range spans $0.78 to $25.00. Analyst consensus is hold with an average price target of $14.00. Rallies surfaces VTYX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes VTYX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $14.00 |
| Market Cap | $1.00B |
| P/E Ratio | -7.11 |
| EPS | $-1.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.00 |
| 52-Week Low | $0.78 |
| Volume | 5.45M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-135.12M |
| Gross Margin | 0.00% |
13 analysts cover VTYX: 0 strong buy, 4 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $14.00.